Patrice Ravel Selected Research

Patrice Ravel Research Topics

13	Neoplasms (Cancer) 01/2023 - 01/2004
4	Renal Cell Carcinoma (Grawitz Tumor) 11/2022 - 11/2010
2	Malaria 01/2023 - 01/2016
2	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2008
2	Melanoma (Melanoma, Malignant) 12/2018 - 04/2010
2	Dystonia (Limb Dystonia) 02/2010 - 04/2004
1	Parasitic Diseases (Parasitic Disease) 01/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023
1	Rectal Neoplasms (Rectal Cancer) 01/2021
1	Colonic Neoplasms (Colon Cancer) 12/2018
1	Rheumatoid Arthritis 07/2014
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2013
1	Lung Neoplasms (Lung Cancer) 05/2012
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2012
1	Hematologic Neoplasms (Hematological Malignancy) 11/2011
1	Kidney Neoplasms (Kidney Cancer) 11/2010
1	Disease Progression 02/2010
1	Dystonia musculorum deformans type 1 02/2010
1	Brain Neoplasms (Brain Tumor) 01/2004

3	Cancer VaccinesIBA 12/2018 - 11/2011
2	VaccinesIBA 01/2023 - 11/2011
2	RNA (Ribonucleic Acid)IBA 11/2022 - 01/2021
2	Sunitinib (Sutent)FDA Link 12/2021 - 11/2010
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2013
2	Peptides (Polypeptides)IBA 12/2018 - 05/2012
2	AntigensIBA 12/2018 - 11/2011
2	temsirolimus FDA Link 12/2018 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2013
2	Telomerase (Telomerase Reverse Transcriptase)IBA 05/2012 - 04/2010
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	GPI-Linked ProteinsIBA 01/2023
1	AntibodiesIBA 01/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	tyrosine receptor (receptor, tyrosine)IBA 01/2023
1	Bispecific AntibodiesIBA 01/2023
1	pazopanib FDA Link 12/2021
1	Angiogenesis InhibitorsIBA 12/2021
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2021
1	Estrogens (Estrogen)FDA Link 01/2021
1	Hormones (Hormone)IBA 01/2021
1	InterferonsIBA 01/2021
1	PlatinumIBA 01/2021
1	CytokinesIBA 01/2021
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2021
1	Shiga Toxin (Shigella Toxin)IBA 12/2018
1	liquid crystal polymerIBA 01/2017
1	artemisinin (artemisinine)IBA 01/2016
1	Everolimus FDA Link 01/2016
1	MTOR InhibitorsIBA 01/2016
1	Tumor Necrosis Factor InhibitorsIBA 07/2014
1	HLA-DR Antigens (HLA-DR)IBA 05/2012
1	EpitopesIBA 05/2012
1	AutoantigensIBA 11/2011
1	HLA-A*02:01 antigenIBA 04/2010
1	Tamoxifen FDA LinkGeneric 01/2008
1	Estrogen Receptor alphaIBA 01/2008
1	Complementary DNA (cDNA)IBA 01/2008
1	Estrogen ReceptorsIBA 01/2008
1	ThalliumIBA 01/2004